MarketBeat is providing consensus rating for Alamar Biosciences, and Leerink Partners and Bank of America have initiated coverage on the company.
1 report, 1 independent
Updated Aug 10
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
MarketBeat is providing consensus rating for Alamar Biosciences, and Leerink Partners and Bank of America have initiated coverage on the company.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
MarketBeat
American personal finance blog
-
Leerink partners
U.S. investment bank
-
Bank of America
American multinational banking and financial services corporation
Related events
- MarketBeat is providing consensus price targets and analyst recommendations for consumer staples companies, including JBS S.A. and Inspire Veterinary Partners.
- MarketBeat provided analyst ratings for Alvotech, a company developing a biosimilar to Humira.
- MarketBeat provided analyst ratings for Bank of America and CNB Financial, comparing the financial performance of the two companies.
- Rapid Micro Biosystems and Thermo Fisher Scientific are competing in the life sciences/healthcare market, with MarketBeat providing analyst ratings and coverage.
- MarketBeat provided analyst ratings and targets for small-cap healthcare companies Emergent BioSolutions and Entrada Therapeutics.